https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-02-28 / Biomedicines 2022 Feb;10(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-02-28 / Biomedicines 2022 Feb;10(3)2022-02-28 00:00:002023-01-31 13:07:22Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-02-16 / Genes Immun 2022 Feb;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-02-16 / Genes Immun 2022 Feb;2022-02-16 00:00:002022-02-21 07:49:56Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-02-15 / Leuk Lymphoma 2022 Jul;63(7):1733-1737
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-02-15 / Leuk Lymphoma 2022 Jul;63(7):1733-17372022-02-15 00:00:002022-02-15 00:00:00Wilms‘ tumor 1 peptide-loaded dendritic cell vaccination in patients with relapsed or refractory malignant lymphoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-02-04 / Curr Oncol 2022 Feb;29(2):881-891
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-02-04 / Curr Oncol 2022 Feb;29(2):881-8912022-02-04 00:00:002023-01-31 12:41:45Delayed Effect of Dendritic Cells Vaccination on Survival in Glioblastoma: A Systematic Review and Meta-Analysis
